摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-甲基哌啶-4-基1-苯基环戊羧酸酯盐酸(1:1) | 1952-11-0

中文名称
1-甲基哌啶-4-基1-苯基环戊羧酸酯盐酸(1:1)
中文别名
——
英文名称
1-Methyl-4-piperidinyl 1-phenylcyclopentanecarboxylate hydrochloride
英文别名
(1-methylpiperidin-4-yl) 1-phenylcyclopentane-1-carboxylate;hydrochloride
1-甲基哌啶-4-基1-苯基环戊羧酸酯盐酸(1:1)化学式
CAS
1952-11-0
化学式
C18H26ClNO2
mdl
——
分子量
323.9
InChiKey
UPHKUNLWUBDUGT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.56
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • PARASYMPATHIKOMIMETIKUM UND PARASYMPATHIKOLYTIKUM ENTHALTENDES TTS
    申请人:LTS LOHMANN Therapie-Systeme AG
    公开号:EP0732924B1
    公开(公告)日:2009-06-10
  • PHARMAZEUTISCHE FORMULIERUNG ZUR PROPHYLAXE BZW. VORBEHANDLUNG EINER VERGIFTUNG DURCH PHOSPHORORGANISCHE CHOLINESTERASEHEMMER
    申请人:LTS Lohmann Therapie-Systeme AG
    公开号:EP0732926B1
    公开(公告)日:2003-02-19
  • Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
    申请人:Bailey George S.
    公开号:US20080139524A1
    公开(公告)日:2008-06-12
    Pharmaceutical formulation for the prophylaxis, pretreatment and treatment of a poisoning caused by exposure to (either singly or as a mixture of agents) organophosphorus cholinesterase inhibitors, vesicating agents, polycyclic aromatic hydrocarbons, and aflatoxin B1. This invention is characterized by active substance comprised of a metaloporphyrin molecule with an associated metal moiety (Cu, Mg) of suitable purity and chemical composition to provide a bioavailable oral dosage form to attain predictable concentrations in target tissues and bodily fluids (plasma, bronchial secretions, etc.) sufficient to counteract the effects of toxic substances through chemical complexation or catalysis of toxin degradation. Although these metaloporphyrins are semisynthetic products of chlorophyll, the preferred starting material is chlorophyll a (Chla) extracted and purified from Spirulina pacifica or other sources. A specific method is invented to achieve a critical combination of purity and yield beyond those currently available.
  • US5939095A
    申请人:——
    公开号:US5939095A
    公开(公告)日:1999-08-17
  • US6114347A
    申请人:——
    公开号:US6114347A
    公开(公告)日:2000-09-05
查看更多